Table 2.
Group differences by study outcomes
| Two-month outcomes | Full sample (N = 349) | Intervention group (n = 181) | Comparison group (n = 168) | F | p |
|---|---|---|---|---|---|
| M ± SD | M ± SD | M ± SD | |||
| Decision conflict | |||||
| Total score | 36.72 ± 12.31 | 36.0 ± 12.03 | 37.50 ± 12.60 | .99 | .32 |
| Subscale scores: | |||||
| Uncertainty | 45.70 ± 19.26 | 45.46 ± 18.49 | 45.97 ± 20.13 | .03 | .86 |
| Informed | 35.54 ± 15.79 | 35.77 ± 15.35 | 35.27 ± 16.30 | .09 | .76 |
| Value Clarity | 35.18 ± 15.55 | 33.98 ± 14.75 | 36.52 ± 16.34 | 1.92 | .17 |
| Support | 36.49 ± 15.98 | 34.82 ± 15.76 | 38.26 ± 16.08 | 3.74 | .05 |
| Effective Decision | 33.45 ± 13.25 | 32.84 ± 13.20 | 34.13 ± 13.32 | .73 | .40 |
| Cancer-related distress | |||||
| Intrusion subscale | 11.64 ± 9.02 | 11.86 ± 9.44 | 11.39 ± 8.54 | .01 | .93 |
| % | % | % | x 2 | p | |
| Clinically significant levels of distress (scores ≥ 20)a | 19.2% | 19.7% | 18.5% | .07 | .79 |
Higher DCS scores indicate higher levels of decisional conflict and higher IES scores indicate higher levels of cancer-related distress.
aBased on validated case rule of IES scores ≥20 indicating clinically significant or elevated levels of distress.